Cyclerion Therapeutics Inc (CYCN) stock news · $8.6M cap
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
This CYCN news page leads with what Cyclerion Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CYCN yet. We will not pad this page with generic market recap.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CYCN stock page; for the tape open the quote page.
Not investment advice.